JP2004528809A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004528809A5 JP2004528809A5 JP2002532629A JP2002532629A JP2004528809A5 JP 2004528809 A5 JP2004528809 A5 JP 2004528809A5 JP 2002532629 A JP2002532629 A JP 2002532629A JP 2002532629 A JP2002532629 A JP 2002532629A JP 2004528809 A5 JP2004528809 A5 JP 2004528809A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- sequence seq
- consensus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 description 10
- 101001130247 Homo sapiens Reticulon-4 receptor-like 2 Proteins 0.000 description 4
- 101001130249 Mus musculus Reticulon-4 receptor-like 1 Proteins 0.000 description 4
- 102000053414 human RTN4RL2 Human genes 0.000 description 4
- 102000000343 Nogo Receptor 1 Human genes 0.000 description 2
- 108010041199 Nogo Receptor 1 Proteins 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 101001130250 Homo sapiens Reticulon-4 receptor-like 1 Proteins 0.000 description 1
- 102000010410 Nogo Proteins Human genes 0.000 description 1
- 108010077641 Nogo Proteins Proteins 0.000 description 1
- 101710095853 Reticulon-4 receptor-like 1 Proteins 0.000 description 1
- 102100031540 Reticulon-4 receptor-like 1 Human genes 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23836100P | 2000-10-06 | 2000-10-06 | |
| PCT/US2001/031488 WO2002029059A2 (en) | 2000-10-06 | 2001-10-06 | Nogo receptor homologs |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009022063A Division JP2009100767A (ja) | 2000-10-06 | 2009-02-02 | Ｎｏｇｏレセプターホモログ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004528809A JP2004528809A (ja) | 2004-09-24 |
| JP2004528809A5 true JP2004528809A5 (enExample) | 2005-03-03 |
| JP4465148B2 JP4465148B2 (ja) | 2010-05-19 |
Family
ID=22897532
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002532629A Expired - Fee Related JP4465148B2 (ja) | 2000-10-06 | 2001-10-06 | Ｎｏｇｏレセプターホモログ |
| JP2009022063A Withdrawn JP2009100767A (ja) | 2000-10-06 | 2009-02-02 | Ｎｏｇｏレセプターホモログ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009022063A Withdrawn JP2009100767A (ja) | 2000-10-06 | 2009-02-02 | Ｎｏｇｏレセプターホモログ |
Country Status (12)
| Country | Link |
|---|---|
| US (5) | US20030124704A1 (enExample) |
| EP (1) | EP1325130B1 (enExample) |
| JP (2) | JP4465148B2 (enExample) |
| AT (1) | ATE458815T1 (enExample) |
| AU (2) | AU1153902A (enExample) |
| CA (1) | CA2424834A1 (enExample) |
| DE (1) | DE60141409D1 (enExample) |
| DK (1) | DK1325130T3 (enExample) |
| ES (1) | ES2341608T3 (enExample) |
| NZ (1) | NZ525422A (enExample) |
| PT (1) | PT1325130E (enExample) |
| WO (1) | WO2002029059A2 (enExample) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7119165B2 (en) * | 2000-01-12 | 2006-10-10 | Yale University | Nogo receptor-mediated blockade of axonal growth |
| DE60141409D1 (de) * | 2000-10-06 | 2010-04-08 | Biogen Idec Inc | Homologe des nogo rezeptors |
| WO2003018631A2 (en) * | 2001-08-27 | 2003-03-06 | Novartis Ag | Nogo receptor homologues and their use |
| EP1440091A1 (en) * | 2001-10-22 | 2004-07-28 | Novartis AG | Nogo receptor homologues and their use |
| US7309485B2 (en) * | 2001-12-03 | 2007-12-18 | Children's Medical Center Corporation | Reducing myelin-mediated inhibition of axon regeneration |
| WO2004005510A1 (ja) * | 2002-07-05 | 2004-01-15 | Shionogi & Co., Ltd. | 新規Nogo受容体様ポリペプチドおよびそのＤＮＡ |
| ES2346868T3 (es) | 2002-08-10 | 2010-10-21 | Yale University | Antagonistas de receptor nogo. |
| CA2519227C (en) | 2003-03-19 | 2013-12-03 | Biogen Idec Ma Inc. | Nogo receptor binding protein |
| US7541335B2 (en) | 2003-04-04 | 2009-06-02 | University Of Rochester | Nogo-receptors and methods of use |
| EA009643B1 (ru) * | 2003-04-16 | 2008-02-28 | Йейл Юниверсити | Лечение состояний, включающих амилоидные бляшки |
| US20080274112A1 (en) * | 2003-08-07 | 2008-11-06 | Lee Daniel H S | Nogo Receptor Antagonists |
| US20080274077A1 (en) * | 2003-12-16 | 2008-11-06 | Children's Medical Center Corporation | Method for Treating Neurological Disorders |
| US8912144B2 (en) * | 2003-12-16 | 2014-12-16 | Children's Medical Center Corporation | Method for treating stroke via administration of NEP1-40 and inosine |
| KR20070052237A (ko) * | 2004-01-30 | 2007-05-21 | 비오겐 아이덱 엠에이 아이엔씨. | 노고 수용체 길항제를 사용한, 도파민성 신경 퇴행을수반하는 상태의 치료법 |
| US8486893B2 (en) | 2004-06-24 | 2013-07-16 | Biogen Idec Ma Inc. | Treatment of conditions involving demyelination |
| EP1805209A4 (en) * | 2004-10-01 | 2008-04-02 | Univ Yale | NOGO-A POLYPEPTIDE FRAGMENTS, VARIANT OF NOGO RECEPTOR-1 POLYPEPTIDES AND USE |
| WO2007008732A2 (en) * | 2005-07-07 | 2007-01-18 | Yale University | Compositions and methods for suppressing axonal growth inhibition |
| HRP20131066T1 (hr) | 2005-07-08 | 2013-12-06 | Biogen Idec Ma Inc. | Sp35 antitijela i njihova upotreba |
| US20090062199A1 (en) * | 2005-08-25 | 2009-03-05 | Biogen Idec Ma Inc. | Nogo Receptor Polypeptides and Polypeptide Fragments and Uses Thereof |
| PT1981902E (pt) | 2006-01-27 | 2015-11-02 | Biogen Ma Inc | Antagonistas dos recetores nogo |
| US20110123535A1 (en) * | 2006-05-15 | 2011-05-26 | Biogen Idec Ma Inc. | Use of Nogo Receptor-1 (NGR1) for Promoting Oligodendrocyte Survival |
| US20080025959A1 (en) * | 2006-05-24 | 2008-01-31 | Richard Daneman | Permeability of blood-brain barrier |
| ES2437110T3 (es) | 2006-11-14 | 2014-01-08 | Genentech, Inc. | Moduladores de la regeneración neuronal |
| US20100047232A1 (en) * | 2006-11-14 | 2010-02-25 | Jasvinder Atwal | Modulators of neuronal regeneration |
| WO2009009743A2 (en) * | 2007-07-12 | 2009-01-15 | Institute For Advance Study | Sequence optimization for expression of a foreign gene |
| RU2010128608A (ru) * | 2007-12-11 | 2012-01-20 | Дженентек, Инк. (Us) | Модуляторы регенерации нейронов |
| EP2276500A4 (en) | 2008-03-13 | 2015-03-04 | Univ Yale | REACTIVATION OF AXON GROWTH AND AXON RECOVERY IN CHRONIC REVERSE MARKET INJURIES |
| CL2009001155A1 (es) * | 2008-05-13 | 2010-06-04 | Genentech Inc | Anticuerpo anti-pirb/lilrb aislado; polinucleotido que lo codifica; vector; celula huesped; metodo de obtencion; composicion farmaceutica que lo comprende; kit; y su uso para tratar enfermedades neurodegenerativas. |
| CA2729961C (en) | 2008-07-09 | 2018-05-01 | Biogen Idec Ma Inc. | Li113, li62 variant co2, anti-lingo antibodies |
| EP2392208B1 (en) * | 2010-06-07 | 2016-05-04 | Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Fusion proteins comprising a DNA-binding domain of a Tal effector protein and a non-specific cleavage domain of a restriction nuclease and their use |
| US9120111B2 (en) | 2012-02-24 | 2015-09-01 | Rain Bird Corporation | Arc adjustable rotary sprinkler having full-circle operation and automatic matched precipitation |
| KR102142161B1 (ko) | 2012-05-14 | 2020-08-06 | 바이오젠 엠에이 인코포레이티드 | 운동 뉴런 관련 병태 치료용 lingo-2 길항제 |
| US9156043B2 (en) | 2012-07-13 | 2015-10-13 | Rain Bird Corporation | Arc adjustable rotary sprinkler with automatic matched precipitation |
| JP2018504400A (ja) | 2015-01-08 | 2018-02-15 | バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． | Ｌｉｎｇｏ‐１拮抗薬及び脱髄障害の治療のための使用 |
| US12343748B2 (en) | 2021-03-16 | 2025-07-01 | Rain Bird Corporation | Multi-mode rotor sprinkler apparatus and method |
| US12434252B2 (en) | 2022-04-20 | 2025-10-07 | Rain Bird Corporation | Full-circle and part-circle rotor sprinkler |
| US12440855B2 (en) | 2022-10-27 | 2025-10-14 | Rain Bird Corporation | Multi-mode rotor sprinkler apparatus and method |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1341050C (en) | 1988-11-04 | 2000-07-11 | Martin E. Schwab | Neurite growth regulatory factors |
| US5250414A (en) | 1988-11-04 | 1993-10-05 | Erziehungsdirektion Of The Canton Zurich | Diagnostic methods using neurite growth regulatory factors |
| EP0396719B1 (en) | 1988-11-04 | 1995-07-05 | Erziehungsdirektion Of The Canton Zurich | Neurite growth regulatory factors |
| CA2117889A1 (en) | 1993-02-11 | 1994-08-18 | Martin E. Schwab | A combination of neurotrophin and antibody directed toward myelin-associated neurite growth inhibitory protein promotes central nervous system regeneration |
| WO2000073452A2 (en) | 1999-06-02 | 2000-12-07 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| US5858708A (en) | 1996-08-12 | 1999-01-12 | Bandman; Olga | Polynucleotides encoding two novel human neuroendocrine-specific proteins |
| EP1002132A4 (en) * | 1997-08-05 | 2005-04-27 | Human Genome Sciences Inc | 90 HUMAN SECRETED PROTEINS |
| ES2312205T3 (es) | 1998-03-10 | 2009-02-16 | Genentech, Inc. | Nuevo polipeptido y acidos nucleicos que lo codifican. |
| CA2331154A1 (en) | 1998-06-16 | 1999-12-23 | Human Genome Sciences, Inc. | Polypeptides having sequence identity with acid labile subunit of insulin-like growth factor |
| JP2002522016A (ja) | 1998-07-22 | 2002-07-23 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 神経内分泌特異的タンパク質に類似したタンパク質、およびそれをコードするｃＤＮＡ |
| CN101684155A (zh) * | 1998-11-06 | 2010-03-31 | 苏黎世大学 | Nogo基因的核苷酸序列和蛋白序列以及基于其的方法 |
| JP3695642B2 (ja) | 1998-12-01 | 2005-09-14 | ジェネンテック・インコーポレーテッド | 血管形成及び心臓血管新生の促進又は阻害 |
| ES2327785T3 (es) | 1998-12-22 | 2009-11-03 | Genentech, Inc. | Procedimientos y compuestos para inhibir el crecimiento de celulas neoplasticas. |
| CA2362427A1 (en) | 1999-03-08 | 2000-09-14 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| EP1263948A2 (en) | 1999-03-08 | 2002-12-11 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| WO2000058473A2 (en) | 1999-03-31 | 2000-10-05 | Curagen Corporation | Nucleic acids including open reading frames encoding polypeptides; 'orfx' |
| AU3632600A (en) | 1999-05-14 | 2000-12-05 | Genentech Inc. | Compositions and methods for the treatment of immune related diseases |
| AU6394400A (en) | 1999-07-30 | 2001-02-19 | Millennium Pharmaceuticals, Inc. | Secreted proteins and uses thereof |
| AU2575901A (en) | 1999-12-08 | 2001-06-18 | Millennium Pharmaceuticals, Inc. | Novel leucine rich repeat-containing molecules and uses therefor |
| US7119165B2 (en) * | 2000-01-12 | 2006-10-10 | Yale University | Nogo receptor-mediated blockade of axonal growth |
| HK1051543A1 (zh) * | 2000-01-12 | 2003-08-08 | Yale University | Nogo受体介导的轴突生长封锁 |
| US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| EP1275411A4 (en) | 2000-04-18 | 2006-04-05 | Teijin Ltd | OXYGEN |
| DE60141409D1 (de) * | 2000-10-06 | 2010-04-08 | Biogen Idec Inc | Homologe des nogo rezeptors |
| WO2003018631A2 (en) | 2001-08-27 | 2003-03-06 | Novartis Ag | Nogo receptor homologues and their use |
| EP1440091A1 (en) | 2001-10-22 | 2004-07-28 | Novartis AG | Nogo receptor homologues and their use |
| ES2346868T3 (es) | 2002-08-10 | 2010-10-21 | Yale University | Antagonistas de receptor nogo. |
-
2001
- 2001-10-06 DE DE60141409T patent/DE60141409D1/de not_active Expired - Lifetime
- 2001-10-06 CA CA002424834A patent/CA2424834A1/en not_active Abandoned
- 2001-10-06 PT PT01979595T patent/PT1325130E/pt unknown
- 2001-10-06 WO PCT/US2001/031488 patent/WO2002029059A2/en not_active Ceased
- 2001-10-06 EP EP01979595A patent/EP1325130B1/en not_active Expired - Lifetime
- 2001-10-06 JP JP2002532629A patent/JP4465148B2/ja not_active Expired - Fee Related
- 2001-10-06 AU AU1153902A patent/AU1153902A/xx active Pending
- 2001-10-06 US US09/972,546 patent/US20030124704A1/en not_active Abandoned
- 2001-10-06 ES ES01979595T patent/ES2341608T3/es not_active Expired - Lifetime
- 2001-10-06 DK DK01979595.4T patent/DK1325130T3/da active
- 2001-10-06 NZ NZ525422A patent/NZ525422A/en unknown
- 2001-10-06 AT AT01979595T patent/ATE458815T1/de active
- 2001-10-06 AU AU2002211539A patent/AU2002211539B2/en not_active Ceased
-
2003
- 2003-12-12 US US10/735,256 patent/US7173118B2/en not_active Expired - Lifetime
-
2006
- 2006-10-06 US US11/544,013 patent/US7456255B2/en not_active Expired - Lifetime
-
2008
- 2008-11-24 US US12/277,187 patent/US20090175850A1/en not_active Abandoned
-
2009
- 2009-02-02 JP JP2009022063A patent/JP2009100767A/ja not_active Withdrawn
-
2010
- 2010-11-23 US US12/952,747 patent/US20110129477A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004528809A5 (enExample) | ||
| JP2004511201A5 (enExample) | ||
| JP2002503641A5 (enExample) | ||
| JP2001524320A5 (enExample) | ||
| JP2001514013A5 (enExample) | ||
| JP2003533986A5 (enExample) | ||
| WO2000022430A3 (en) | Neisseria genomic sequences and methods of their use | |
| BR0010361A (pt) | Seq ências genÈmicas de neisseria e uso destas | |
| CN108779465A (zh) | 用于减少pd-l1表达的寡核苷酸 | |
| JP2021090458A5 (enExample) | ||
| MX339406B (es) | Antigenos de neisseria meningitidis y composiciones que los contienen. | |
| EP1246114A3 (en) | Methods for genomic analysis | |
| CA2143678A1 (en) | Compositions and methods for treatment of hepatitis c virus-associated diseases | |
| ATE289519T1 (de) | Zusammensetzungen und verfahren zur behandlung von hepatitis c virus-bedingten erkrankungen | |
| JP2009537143A5 (enExample) | ||
| CA2378148A1 (en) | Nematicidal trifluorobutenes | |
| CA2520541A1 (en) | Antisense oligonucleotides (odn) against smad7 and uses thereof in medical field | |
| JP2001512666A5 (enExample) | ||
| JP2003525623A5 (enExample) | ||
| JP2008528624A5 (enExample) | ||
| JP2004526737A5 (enExample) | ||
| JP2003246788A5 (enExample) | ||
| SE9702002D0 (sv) | Novel compounds | |
| JP2023549563A5 (enExample) | ||
| WO2004027062A3 (de) | Funktionelle korrektur der -786 c/t-varianz des humanen enos-gens |